BeiGene Ltd. (49B) — Cash Flow Reinvestment Rate

Latest as of March 2025: 5.41x

BeiGene Ltd. (49B) has a Cash Flow Reinvestment Rate of 5.41x as of March 2025, reinvesting €238.35 Million (capex €116.41 Million plus investments €-121.94 Million) from operating cash flow of €44.08 Million. Check BeiGene Ltd. (49B) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

5.41x

(Capex + Investments) / Operating CF

Total Reinvested

€238.35 Million

Capex + Investments

Operating Cash Flow

€44.08 Million

EUR

Capital Expenditures

€116.41 Million

EUR

BeiGene Ltd. Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for BeiGene Ltd. across 1 annual periods. Explore investment intensity of BeiGene Ltd. to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for BeiGene Ltd. (2017–2017)

Year-by-year capital reinvestment analysis for BeiGene Ltd.. For live market cap and broader valuation context, see BeiGene Ltd. market capitalisation.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2017	28.54x	€363.88 Million	€12.75 Million	€46.37 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow